Saturday 17 October 2026
Export DRIO’s income statement to Excel — free account
DarioHealth Corp.
DRIO Healthcare Health Information Services
DarioHealth Corp.’s revenue for fiscal 2025 (year ended December 2025) was $22.4 million, down 17.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.58%, EPS grew 76.4%, free cash flow was flat and total debt rose 1.85%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.95
0.18
−3.51%
Follow DRIO
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | 4 | 4 | 3 | 3 | 4 | 2 | 5 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(28.56) | (19.70) | (11.71) | (5.91) | (0.27) | 3.47 | (2.68) | (5.59) | (5.24) | (5.72) |
P/S ratio |
0.29 | 0.15 | 0.12 | 1.97 | 11.25 | 10.49 | 3.72 | 2.36 | 1.43 | 2.03 |
Altman Z″-Score (non-manufacturers) |
(66.18) | (42.95) | (23.58) | (11.23) | (9.77) | (4.35) | (6.34) | (11.77) | (11.04) | (12.40) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (6.52) | (3.84) | (1.77) | (2.28) | 8.32 | (2.65) | (4.20) | (2.34) | (3.58) |
P/Operating CF |
(0.44) | (0.32) | (0.26) | (5.21) | (12.61) | (14.22) | (12.95) | (6.53) | (5.73) | (7.70) |
P/B ratio |
0.00 | 0.20 | 0.10 | 0.79 | 3.03 | 2.52 | 1.29 | 0.82 | 0.54 | 0.67 |
Price to Tangible BV |
0.00 | 0.20 | 0.10 | 0.79 | 3.03 | 6.84 | 3.61 | 4.32 | 0.00 | 0.00 |
EV/Sales |
(0.18) | (0.62) | (1.39) | (0.65) | 7.52 | 8.75 | 2.90 | 1.94 | 1.44 | 2.69 |
EV/EBITDA |
0.05 | 0.23 | 0.59 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.06 | 0.30 | 0.90 | 0.31 | (3.21) | (3.56) | (1.68) | (1.30) | (1.01) | (2.32) |
EV/FCF |
0.05 | 0.29 | 0.89 | 0.31 | (3.19) | (3.54) | (1.65) | (1.26) | (0.99) | (2.27) |
Quick Ratio |
0.70 | 1.61 | 2.27 | 4.12 | 4.53 | 2.74 | 2.98 | 3.38 | 2.15 | 3.30 |
Current Ratio |
1.00 | 2.01 | 2.54 | 4.39 | 4.85 | 3.17 | 3.39 | 3.79 | 2.44 | 3.76 |
Net Debt/EBITDA |
0.12 | 0.28 | 0.64 | 1.13 | 0.96 | 0.50 | 0.43 | 0.17 | (0.01) | (0.13) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 3.14% | 1.50% | 0.28% | 22.59% | 29.61% | 24.33% | 27.93% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.04 | 0.02 | 0.00 | 0.34 | 0.49 | 0.40 | 0.45 |
Asset Turnover |
0.63 | 0.95 | 0.70 | 0.39 | 0.25 | 0.30 | 0.25 | 0.19 | 0.25 | 0.20 |
Operating CF/Net income |
0.72 | 0.66 | 0.63 | 0.75 | 0.54 | 0.64 | 0.75 | 0.48 | 0.94 | 0.42 |
Capex/Depreciation |
(2.09) | (1.00) | (0.34) | (0.54) | (0.26) | (0.06) | (0.12) | (0.12) | (0.02) | (0.05) |
Interest Coverage |
— | — | (152.48) | (571.13) | 65.29 | (325.51) | (10.56) | (17.70) | 4.39 | (7.40) |
| 285.85% | 1,230.62% | (284.41%) | (150.19%) | (140.73%) | (138.55%) | (77.12%) | (91.95%) | (62.97%) | (88.23%) | |
| (259.40%) | (295.47%) | (173.87%) | (108.08%) | (110.39%) | (115.68%) | (58.04%) | (58.92%) | (38.07%) | (53.93%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (95.93%) | (61.85%) | (70.80%) | (49.91%) | (31.63%) |
Return on Tangible Assets |
(1,272.70%) | (410.21%) | (211.00%) | (113.74%) | (119.63%) | (246.68%) | (135.93%) | (177.72%) | (166.57%) | (234.80%) |
Average Days of Receivables |
95.06 | 62.55 | 27.05 | 45.34 | 147.33 | 60.09 | 106.19 | 92.88 | 96.38 | 73.54 |
Research and Development Expense of Revenue |
76.85% | 63.77% | 49.72% | 48.84% | 58.51% | 83.94% | 71.05% | 99.49% | 89.42% | 61.68% |
Selling, General and Administrative Expense of Revenue |
289.58% | 240.48% | 213.38% | 219.74% | 369.36% | 308.28% | 169.28% | 206.00% | 173.20% | 158.90% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.54 | 0.43 | 0.49 | 0.64 | 0.67 |
Share Based Compensation of Revenue |
37.03% | 73.97% | 50.82% | 29.86% | 146.54% | 121.73% | 61.38% | 96.80% | 58.42% | 41.88% |
Graham Net Nets |
(9.10) | 3.90 | 8.73 | 1.16 | 0.32 | 0.14 | 0.26 | 0.19 | (0.16) | (0.16) |
Graham Number |
2,992.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(1,251.23%) | (3,369.22%) | (2,061.86%) | (122.97%) | (40.83%) | (32.23%) | (60.46%) | (120.13%) | (112.17%) | (91.65%) |
Free Cash Flow Yield |
(1,118.18%) | (1,445.32%) | (1,268.98%) | (106.44%) | (20.95%) | (23.55%) | (47.32%) | (65.33%) | (101.34%) | (58.34%) |
Revenue per Share |
215.62 | 214.52 | 126.18 | 66.72 | 25.41 | 24.73 | 23.40 | 14.35 | 11.03 | 5.61 |
Operating CF per Share |
(644.54) | (440.62) | (195.73) | (138.79) | (59.48) | (60.76) | (40.48) | (21.41) | (15.73) | (6.51) |
Capex per Share |
(62.15) | (8.09) | (1.21) | (0.86) | (0.40) | (0.31) | (0.48) | (0.41) | (0.06) | (0.04) |
Free Cash Flow per Share |
(706.69) | (448.71) | (196.95) | (139.66) | (59.87) | (61.08) | (40.97) | (21.83) | (15.78) | (6.55) |
Cash per Share |
101.38 | 164.98 | 190.73 | 181.69 | 96.50 | 43.39 | 41.90 | 26.14 | 11.68 | 6.59 |
Shareholders Equity per Share |
(503.15) | 163.53 | 152.30 | 166.76 | 94.40 | 103.12 | 67.69 | 40.99 | 29.37 | 17.05 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(503.15) | 163.53 | 152.30 | 166.76 | 94.40 | 103.12 | 67.69 | 40.99 | 29.37 | 17.05 |
Free Cash Flow |
(9.19) | (10.81) | (11.54) | (15.82) | (17.85) | (50.67) | (48.42) | (30.96) | (38.70) | (26.08) |
Working Capital |
0.01 | 3.03 | 7.94 | 17.72 | 27.09 | 31.23 | 46.17 | 34.84 | 23.89 | 25.74 |
Capital Expenditures |
(0.81) | (0.19) | (0.07) | (0.10) | (0.12) | (0.26) | (0.57) | (0.58) | (0.14) | (0.14) |
Net Current Asset Value |
(7.48) | 3.03 | 7.94 | 17.26 | 26.87 | 30.38 | 26.33 | 9.09 | (6.34) | (7.09) |
EV/EBIT |
0.04 | 0.22 | 0.58 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.29 | 0.04 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.03 | 0.01 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.43 | 0.22 | 0.28 | 0.28 | 0.79 | 6.35 | 5.99 | 5.55 | 10.48 | 5.72 |
Cash ROIC |
175.90% | (136.59%) | (57.41%) | (39.31%) | (31.07%) | (41.59%) | (30.95%) | (25.01%) | (29.87%) | (20.88%) |
Accounts Receivable Turnover |
3.37 | 6.40 | 10.31 | 10.17 | 3.79 | 6.38 | 4.84 | 3.08 | 4.39 | 3.84 |
Accounts Payable Turnover |
2.60 | 2.11 | 2.54 | 2.35 | 2.45 | 4.36 | 4.84 | 8.32 | 6.60 | 3.25 |
Inventory Turnover |
4.88 | 3.72 | 4.40 | 3.56 | 2.73 | 3.88 | 2.54 | 2.21 | 2.81 | 2.14 |
Average Days of Payables |
182.05 | 175.17 | 166.91 | 121.81 | 178.79 | 112.68 | 47.08 | 28.73 | 80.70 | 110.25 |
Days of Inventory on Hand |
89.22 | 111.99 | 89.29 | 104.01 | 165.31 | 137.35 | 161.32 | 128.59 | 125.96 | 162.51 |
Average Receivables |
0.83 | 0.81 | 0.72 | 0.74 | 2.00 | 3.22 | 5.71 | 6.61 | 6.16 | 5.82 |
Average Payables |
1.40 | 1.83 | 2.21 | 2.12 | 2.07 | 3.79 | 3.72 | 1.73 | 2.09 | 2.99 |
Average Inventory |
0.74 | 1.04 | 1.28 | 1.40 | 1.85 | 4.26 | 7.09 | 6.51 | 4.91 | 4.53 |
Average Assets |
4.47 | 5.41 | 10.52 | 19.33 | 29.99 | 68.09 | 109.98 | 107.79 | 107.64 | 114.48 |
Average Common Equity |
(4.06) | (1.30) | 6.43 | 13.91 | 23.52 | 56.85 | 82.77 | 69.07 | 65.08 | 69.97 |
Columns are period end dates